miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas
Journal of Neuro-Oncology, 08/16/2012
Shi L et al. – The results highlight a novel molecular interaction between miR–335 and Rb1, and miR–335 may represent a potential novel therapeutic agent to target the proliferation of meningioma cells.



